National Cancer Institute; Notice of Closed Meetings, 64655-64656 [07-5677]

Download as PDF 64655 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices ANNUAL BURDEN ESTIMATES—Continued Number of respondents Instrument Number of responses per respondent Average burden hours per response 2 54 54 3,045 3,045 1 25,200 12,000 447 213 240 .046 .083 .029 .083 480 62,597 53,784 39,472 53,833 54 52 2.82 7,919 307.5(a) System, Certification ......................................................................... 307.11(e)(1)(ii), Collection of Non-IV–D Data for SCR—States ..................... Collection of Child Data for IV–D Cases for SCR—States ............................. 307.11(e)(1)(ii), Collection of Non-IV–D Data for SCR—Courts ..................... 307.11(e)(3)(v), Collection of Child Data for IV–D cases for SCR—Courts ... 307.11(f)(1), Case Data Transmitted from SCR to FCR—New cases and case updates ................................................................................................ Estimated Total Annual Burden Hours: 218,709. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families; Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202–395–6974, Attn: Desk Officer for the Administration for Children and Families. November 7, 2007. Robert Sargis, Reports Clearance Officer. [FR Doc. 07–5652 Filed 11–15–07; 8:45 am] BILLING CODE 4184–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on PROD1PC66 with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title U.S.C., as amended. The grant applications and the discussions could disclose VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee A—Cancer Centers. Date: December 6–7, 2007. Time: 8 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Gail J. Bryant, MD, Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8042, Bethesda, MD 20852– 7405, (301) 402–0801. Name of Committee: National Cancer Institute Special Panel; Cancer Center Support Grant. Dated: December 6, 2007 Time: 2:40 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: David E. Maslow, PhD, Chief, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard—Room 8117, Bethesda, MD 20892–7405, (301) 496– 2330. Name of Committee: National Cancer Institute Special Emphasis Panel; Prevention, Control and Population Sciences. Date: January 30–31, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878. Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8131, Bethesda, MD 20892, 301–594–1402, lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Molecular Oncology. PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 Total burden hours Date: February 6–8, 2008. Time: 5:30 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Michael B. Small, PhD, Scientific Review Administrator, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 20892–8328, 301–402–0996, smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE in Lymphoma, Myeloma, Pancreas, GI, H&N and Lung Cancers. Date: February 12–14, 2008. Time: February 12, 2008, 8 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda, 5151 Pooks Hill Rd., Bethesda, MD 20814. Contact Person: Shamala K. Srinivas, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892, 301–594–1224, ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SPORE in Breast, Gynecologic, Genitourinary and Prostate Cancers. Date: February 12–14, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Caron Lyman, PhD, Scientific Review Administrator, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8119, Bethesda, MD 20892–8328, 301–451–4761, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Application of Emerging Technologies for Cancer Research. Date: March 19–20, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Marvin L. Salin, PhD, Scientific Review Administrator, Special E:\FR\FM\16NON1.SGM 16NON1 64656 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–496– 0694, msalin@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer Control, National Institutes of Health, HHS) Dated: November 7, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5677 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Meeting mstockstill on PROD1PC66 with NOTICES Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applicants and/ or contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: February 1, 2008. Closed: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications and/or proposals. Open: 1 p.m. to 4:30 p.m. VerDate Aug<31>2005 21:48 Nov 15, 2007 Jkt 214001 Agenda: Opening remarks by the Acting Director of National Center for Complementary and Alternative Medicine, presentation of a new research initiative, and other business of the Council. Place: National Institutes of Health, Neuroscience Building, 6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD 20892. Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, National Center for Complementary, and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–2014. The public comments session is scheduled from 4–4:30 p.m., but could change depending on the actual time spent on each agenda item. Each speaker wil be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Martin H. Goldrosen, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594–2014, Fax: 301–480–9970. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 p.m. on January 30, 2008. Only one representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Martin H. Goldrosen at the address listed above up to ten calendar days (February 11, 2008) following the meeting. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Martin H. Goldrosen, Executive Secretary, NACCAM, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594– 2014, Fax 301–480–9970, or via e-mail at naccames@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Dated: November 7, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5665 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M PO 00000 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; Pathways to Independence K99/R00 Applications. Date: November 27, 2007. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. Name of Committee: National Eye Institute Special Emphasis Panel; Pathways to Independence Applications II. Date: November 28, 2007. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Eye Institute, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Anne E. Schaffner, PhD, Scientific Review Administrator, Division of Extramural Research, National Eye Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892–9300, (301) 451–2020, aes@nei.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.867, Vision Research, National Institutes of Health, HHS) Dated: November 6, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5664 Filed 11–15–07; 8:45 am] BILLING CODE 4140–01–M Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1

Agencies

[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Pages 64655-64656]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5677]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee A--Cancer Centers.
    Date: December 6-7, 2007.
    Time: 8 a.m. to 11 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Gail J. Bryant, MD, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6116 Executive Boulevard, Room 8042, Bethesda, MD 20852-
7405, (301) 402-0801.

    Name of Committee: National Cancer Institute Special Panel; 
Cancer Center Support Grant.
    Dated: December 6, 2007
    Time: 2:40 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: David E. Maslow, PhD, Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard--Room 8117, Bethesda, MD 20892-7405, (301) 496-2330.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevention, Control and Population Sciences.
    Date: January 30-31, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard Gaithersburg Washingtonian Center, 204 
Boardwalk Place, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd. Room 8131, Bethesda, MD 20892, 301-594-1402, 
lopacw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Molecular Oncology.
    Date: February 6-8, 2008.
    Time: 5:30 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Michael B. Small, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8127, Bethesda, MD 20892-8328, 301-402-0996, smallm@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Lymphoma, Myeloma, Pancreas, GI, H&N and Lung 
Cancers.
    Date: February 12-14, 2008.
    Time: February 12, 2008, 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda, 5151 Pooks Hill Rd., Bethesda, MD 
20814.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Administrator, Research Programs Review Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8123, Bethesda, 
MD 20892, 301-594-1224, ss537t@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Breast, Gynecologic, Genitourinary and Prostate 
Cancers.
    Date: February 12-14, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Caron Lyman, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Blvd., Room 
8119, Bethesda, MD 20892-8328, 301-451-4761, lymanc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Application of Emerging Technologies for Cancer Research.
    Date: March 19-20, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Marvin L. Salin, PhD, Scientific Review 
Administrator, Special

[[Page 64656]]

Review and Logistics Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard, Room 7073, 
Bethesda, MD 20892-8329, 301-496-0694, msalin@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-5677 Filed 11-15-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.